Market revenue in 2023 | USD 2,596.6 million |
Market revenue in 2030 | USD 5,191.6 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Regulatory writing & publishing |
Fastest growing segment | Legal Representation |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
Key market players worldwide | Labcorp Holdings Inc, Icon PLC, IQVIA Holdings Inc, Intertek Group PLC, SGS AG, Promedica International, Integer Holdings Corp, Medpace Holdings Inc, Emergo Group, Freyr Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 61.02% in 2023. Horizon Databook has segmented the Asia Pacific medical device regulatory affairs market based on legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific medical device regulatory affairs market held the largest share of 37.5% in 2022 and is expected to witness lucrative growth owing to the availability of several opportunities in this region, especially in Japan, China, and India.
The low-cost manufacturing possibilities in the Asia Pacific region attract medical device manufacturers. The increasing number of medical device companies investing in the region is a major factor driving the market.
In addition, the growing outsourcing of healthcare services to Asia Pacific, improving regulatory landscape, growing number of clinical trials, and an increasing number of medical device companies venturing into the region are among the major factors boosting the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific medical device regulatory affairs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific medical device regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account